Interestingly, renal oncocytomas, which are considered to be the benign counterpart of chRCC, were found to have a similar increase of GSH moieties and decreased levels of GGT1 relative to normal kidney tissue [61]. The gene discussed is GGT1; the disease is chromophobe renal cell carcinoma.